In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase

Chemotherapy

Volumn 42, Issue 5, 1996, Pages 324-328

  Tzouvelekis, L S ^a   Prinarakis, E E ^a   Gazouli, M ^a   Miriagou, V ^a   Tzelep, E ^a   Legakis, N J ^b  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cefetamet; Enterobacteria; SHV 5 lactamase; Lactam resistance

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE; CEFETAMET; CEFOTAXIME; CEFTAZIDIME; PENICILLIN G;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG HYDROLYSIS; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SERRATIA MARCESCENS;

EID: 0029837052     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239462     Document Type: Article

References (15)

1. Greek Society for Microbiology: Antibiotic resistance among gram-negative bacilli in 19 Greek hospitals. J Hosp Infect 1989;14:169-171.
2. Legakis NJ, Tzouvelekis LS, Tsakris A, Legakis JN. Vatopoulos AC: On the incidence of antibiotic resistance among gram negative rods isolated in Greek hospitals. J Hosp Infect 1993;24:233-237.
3. Vatopoulos AC, Philippon A, Tzou-velekis LS, Komninou Z, Legakis NJ: Prevalence of a transferable SHV-5 type ß-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J An-timicrob Chemother 1990;26:635-648.
4. Gianneli D, Tzelepi E, Tzouvelekis LS, Mentis AF, Nicolopulou C: Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type bcta-lactamase in Greek hospitals. Eur J Clin Microbiol Infect Dis 1994:13: 764-767.
5. Legakis NJ, Tzouvelekis LS, Hat-zoudis G. Tzelepi E, Gourkou A, Pitt TL, Vatopoulos AC: Klebsiella pneumoniae infections in Greek hospitals: Dissemination of plasmids encoding an SHV-5 type beta-lactamase. J Hosp Infect 1995;31: 177-187.
6. Tzouvelekis LS, Tzelepi E, Mentis AF, Tsakris A: Identification of a novel plasmid-mediated ß-lacta-mase with chromosomal cephalo-sporinase characteristics from Klebsiella pneumoniae. J Antimicrob Chemother 1993;31:645-654.
7. Matthew M, Harris AM, Marshall MJ, Ross GW: The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975;88:169-178.
8. Bauernfeind A, Jungwirth R, Schweighart S, Theopold M: Antibacterial activity and beta-lacta-mase stability of eleven oral cephalosporins. Infection 1990;18(suppl 3): 155-167.
9. Cullmann W: The threat of resistance to the new oral cephalosporins. Chemotherapy 1992;38(suppl 2): 10-17.
10. Philippon A, Labia R. Jacoby G: Ex-tended-spectrum β-lactamases. An-timicrob Agents Chemother 1989; 33:1131-1136.
11. Yoshimura F, Nikaido H: Diffusion of β-lactam antibiotics through the porin channels of Echerichia coli K-12. Antimicrob Agents Chemother 1985;27:84-92.
12. Satta G, Comaglia G, Ligozzi M, Bauernfcind A, Fontana R: Diffusion of cafetamct through the outer membrane of Escherichia coli and affinity for penicillin-binding proteins; in Proceedings of the 18th International Congress of Chemotherapy, Stockholm, Sweden, 1993. Washington, American Society for Microbiology.
13. Du Bois SK, Marriott MS, Amyes SGB: TEM- and SHV-derived ex-tended-spectrum β-lactamases: Relation between selection, structure and function. J Antimicrob Chemother 1985;35:7-22.
14. Rice LB, Yao JDC, Klimm K, Elio-poulos GM. Moellcring RC Jr: Efficacy of different ß-lactams against an extcnded-spectrum (5-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Antimicrob Agents Chemother 1991;35:1243-1244.
15. Fantin B, Pangon B, Potel G, Caron F, Vallee E, Vallois JM, Mohlcr J, Bure A, Philippon A, Carbon C: Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-likc β-lactamase. Antimicrob Agents Chemother 1990;34:581-586.